These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16444795)

  • 1. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
    Wålinder J; Prochazka J; Odén A; Sjödin I; Dahl ML; Ahlner J; Bengtsson F
    Hum Psychopharmacol; 2006 Apr; 21(3):151-8. PubMed ID: 16444795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of mirtazapine in patients with chronic pain and concomitant depression.
    Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
    Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP; Nelson JC; Salzman C; Hollander SB; Rodrigues H;
    Curr Med Res Opin; 2003; 19(8):737-46. PubMed ID: 14687445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
    van Moffaert M; de Wilde J; Vereecken A; Dierick M; Evrard JL; Wilmotte J; Mendlewicz J
    Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
    Kim SW; Shin IS; Kim JM; Kim YC; Kim KS; Kim KM; Yang SJ; Yoon JS
    Psychiatry Clin Neurosci; 2008 Feb; 62(1):75-83. PubMed ID: 18289144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
    Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.
    Grasmäder K; Verwohlt PL; Kühn KU; Frahnert C; Hiemke C; Dragicevic A; von Widdern O; Zobel A; Maier W; Rao ML
    Pharmacopsychiatry; 2005 May; 38(3):113-7. PubMed ID: 15902580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.
    Saiz-Ruiz J; Montes JM; Ibáñez A; Díaz M; Vicente F; Pelegrín C; Viñas R; Arias F; Carrasco JL; Ferrando L
    Hum Psychopharmacol; 2005 Aug; 20(6):435-40. PubMed ID: 16106478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older.
    Nelson JC; Hollander SB; Betzel J; Smolen P;
    Int J Geriatr Psychiatry; 2006 Sep; 21(9):898-901. PubMed ID: 16955423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
    Poyurovsky M; Pashinian A; Weizman R; Fuchs C; Weizman A
    Biol Psychiatry; 2006 Jun; 59(11):1071-7. PubMed ID: 16497273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study.
    Yoon SJ; Pae CU; Kim DJ; Namkoong K; Lee E; Oh DY; Lee YS; Shin DH; Jeong YC; Kim JH; Choi SB; Hwang IB; Shin YC; Cho SN; Lee HK; Lee CT
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1196-201. PubMed ID: 16624467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania.
    Danileviciūte V; Sveikata A; Adomaitiene V; Gumbrevicius G; Fokas V; Sveikatiene R
    Medicina (Kaunas); 2009; 45(10):778-84. PubMed ID: 19996664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia.
    Mrakotsky C; Masek B; Biederman J; Raches D; Hsin O; Forbes P; de Moor C; DeMaso DR; Gonzalez-Heydrich J
    J Anxiety Disord; 2008; 22(1):88-97. PubMed ID: 17419001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study.
    Gambi F; De Berardis D; Campanella D; Carano A; Sepede G; Salini G; Mezzano D; Cicconetti A; Penna L; Salerno RM; Ferro FM
    J Psychopharmacol; 2005 Sep; 19(5):483-7. PubMed ID: 16166185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset of antidepressant action: a pharmacological question?
    Rojo JE; Gibert K; Cobo J; Rodriguez-Cano E; Vallejo J
    Hum Psychopharmacol; 2005 Aug; 20(6):425-33. PubMed ID: 16106477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.